Bill > HB414

This bill requires insurance coverage for preventative PFAS (per- and polyfluoroalkyl substances) care. Specifically, it mandates that individual and group health insurance policies in New Hampshire cover medical treatment for individuals with elevated levels of PFAS chemicals in their blood, as recommended by the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. The bill prohibits insurers from subjecting this coverage to higher co-payments, deductibles, or coinsurance than other similar benefits. The fiscal impact of this bill is indeterminable, as the coverage required may already be included under existing health plan categories, but could potentially lead to increased premium costs and state funding obligations if considered an "additional" required benefit under federal regulations.

Business and Industry

https://gc.nh.gov/bill_status/legacy/bs2016/bill_status.aspx?lsr=581&sy=2024&sortoption=&txtsessionyear=2024&txtbillnumber=HB414